ProQR Therapeutics N.V. - Ordinary Shares (PRQR): Price and Financial Metrics
ProQR Therapeutics N.V. - Ordinary Shares (PRQR)
Today's Latest Price: $3.83 USD
Updated Oct 29 1:00pm
Add PRQR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
PRQR Stock Summary
- PRQR's price/sales ratio is 90.56; that's higher than the P/S ratio of 97.12% of US stocks.
- With a year-over-year growth in debt of 175.06%, ProQR Therapeutics NV's debt growth rate surpasses 91.51% of about US stocks.
- As for revenue growth, note that PRQR's revenue has grown -41.35% over the past 12 months; that beats the revenue growth of just 5.91% of US companies in our set.
- Stocks that are quantitatively similar to PRQR, based on their financial statements, market capitalization, and price volatility, are AUTL, DNLI, AGIO, FATE, and RGNX.
- Visit PRQR's SEC page to see the company's official filings. To visit the company's web site, go to www.proqr.com.
PRQR Stock Price Chart Interactive Chart >
PRQR Price/Volume Stats
| Current price | $3.83 | 52-week high | $10.98 |
| Prev. close | $3.91 | 52-week low | $3.76 |
| Day low | $3.76 | Volume | 57,737 |
| Day high | $3.99 | Avg. volume | 182,395 |
| 50-day MA | $4.90 | Dividend yield | N/A |
| 200-day MA | $5.77 | Market Cap | 192.05M |
ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Company Bio
ProQR Therapeutics is a biopharmaceutical company, focused on RNA medicines for the treatment of severe diseases such as cystic fibrosis and Leber's congenital amaurosis. The company was founded in 2012 and is based in Leiden, the Netherlands.
Loading social stream, please wait...